Lactic dehydrogenase isoenzymes in the cerebrospinal fluid of patients with systemic cancer

Lactic dehydrogenase (LDH) isoenzymes were measured in the cerebrospinal fluid (CSF) in a group of patients suffering a variety of cancer‐related neurologic problems. LDH‐5 isoenzyme as a percentage of total LDH activity was abnormally elevated (above 10 to 15%) in leptomeningeal infiltration by car...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer 1981-06, Vol.47 (11), p.2654-2659
Hauptverfasser: Fleisher, Martin, Wasserstrom, William R., Schold, S. Clifford, Schwartz, Morton K., Posner, Jerome B.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2659
container_issue 11
container_start_page 2654
container_title Cancer
container_volume 47
creator Fleisher, Martin
Wasserstrom, William R.
Schold, S. Clifford
Schwartz, Morton K.
Posner, Jerome B.
description Lactic dehydrogenase (LDH) isoenzymes were measured in the cerebrospinal fluid (CSF) in a group of patients suffering a variety of cancer‐related neurologic problems. LDH‐5 isoenzyme as a percentage of total LDH activity was abnormally elevated (above 10 to 15%) in leptomeningeal infiltration by carcinoma (breast carcinoma, lung carcinoma, and malignant melanoma) but not in other types of CNS metastases. Abnormal LDH isoenzyme patterns were also seen with CSF infections in which a granulocytic pleocytosis was present. In the absence of infection, an elevated LDH isoenzyme 5:1 ratio suggested leptomeningeal tumor and, when used with other CSF markers (beta‐glucuronidase and CEA), LDH isoenzymes aid in early detection of this metastatic neoplastic process. They may also help to differentiate leptomeningeal tumor from other chronic meningitides. Measurement of CSF markers also aids in assessing the effectiveness of treatment since marker levels often vary with the clinical course.
doi_str_mv 10.1002/1097-0142(19810601)47:11<2654::AID-CNCR2820471122>3.0.CO;2-Z
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73504535</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73504535</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4722-846f490003fadbb907fed37ef60f8b6293b0d617fec677b90c7da9688a702613</originalsourceid><addsrcrecordid>eNqVkN9r1EAQxxdR6ln9E4R9En3IOfsju8lZhJL6o3B4IH2QKgybZNJbySVnNkdJ__rucWdBHwSfhpnvzHdmPoxdCJgLAPlWQG4TEFq-FnkmwIB4o-1CiDNpUr1YnF9eJMWX4qvMJGgrhJTv1RzmxeqdTK4fsdnD-GM2A4AsSbX69pQ9C-FnTK1M1Qk7sdJAltoZ-7501egrXtN6qof-hjoXiPvQU3c3bShw3_FxTbyigcqhD1vfuZY37c7XvG_41o2eujHwWz-ueZjCSJvoVrkuDjxnTxrXBnpxjKfs6uOHq-Jzslx9uizOl0mlrZRJpk2j83ibalxdljnYhmplqTHQZKWRuSqhNiJWK2Nt1Ctbu9xkmbMgjVCn7NXBdjv0v3YURtz4UFHbuo76XUCrUtCpSmPjj0NjFR8JAzW4HfzGDRMKwD163LPDPTv8jR61RSFwjx4xosc_0aNCwGKFEq-j_cvjHbtyQ_WD-ZF11G8O-q1vafrP3f9c_Zei7gETA6KF</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73504535</pqid></control><display><type>article</type><title>Lactic dehydrogenase isoenzymes in the cerebrospinal fluid of patients with systemic cancer</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Fleisher, Martin ; Wasserstrom, William R. ; Schold, S. Clifford ; Schwartz, Morton K. ; Posner, Jerome B.</creator><creatorcontrib>Fleisher, Martin ; Wasserstrom, William R. ; Schold, S. Clifford ; Schwartz, Morton K. ; Posner, Jerome B.</creatorcontrib><description>Lactic dehydrogenase (LDH) isoenzymes were measured in the cerebrospinal fluid (CSF) in a group of patients suffering a variety of cancer‐related neurologic problems. LDH‐5 isoenzyme as a percentage of total LDH activity was abnormally elevated (above 10 to 15%) in leptomeningeal infiltration by carcinoma (breast carcinoma, lung carcinoma, and malignant melanoma) but not in other types of CNS metastases. Abnormal LDH isoenzyme patterns were also seen with CSF infections in which a granulocytic pleocytosis was present. In the absence of infection, an elevated LDH isoenzyme 5:1 ratio suggested leptomeningeal tumor and, when used with other CSF markers (beta‐glucuronidase and CEA), LDH isoenzymes aid in early detection of this metastatic neoplastic process. They may also help to differentiate leptomeningeal tumor from other chronic meningitides. Measurement of CSF markers also aids in assessing the effectiveness of treatment since marker levels often vary with the clinical course.</description><identifier>ISSN: 0008-543X</identifier><identifier>EISSN: 1097-0142</identifier><identifier>DOI: 10.1002/1097-0142(19810601)47:11&lt;2654::AID-CNCR2820471122&gt;3.0.CO;2-Z</identifier><identifier>PMID: 7260857</identifier><language>eng</language><publisher>New York: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Brain Neoplasms - diagnosis ; Brain Neoplasms - secondary ; Breast Neoplasms ; Carcinoembryonic Antigen - cerebrospinal fluid ; Female ; Glucuronidase - cerebrospinal fluid ; Humans ; Isoenzymes ; L-Lactate Dehydrogenase - cerebrospinal fluid ; Lung Neoplasms ; Male ; Melanoma ; Meningeal Neoplasms - diagnosis ; Meningeal Neoplasms - secondary</subject><ispartof>Cancer, 1981-06, Vol.47 (11), p.2654-2659</ispartof><rights>Copyright © 1981 American Cancer Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4722-846f490003fadbb907fed37ef60f8b6293b0d617fec677b90c7da9688a702613</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7260857$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fleisher, Martin</creatorcontrib><creatorcontrib>Wasserstrom, William R.</creatorcontrib><creatorcontrib>Schold, S. Clifford</creatorcontrib><creatorcontrib>Schwartz, Morton K.</creatorcontrib><creatorcontrib>Posner, Jerome B.</creatorcontrib><title>Lactic dehydrogenase isoenzymes in the cerebrospinal fluid of patients with systemic cancer</title><title>Cancer</title><addtitle>Cancer</addtitle><description>Lactic dehydrogenase (LDH) isoenzymes were measured in the cerebrospinal fluid (CSF) in a group of patients suffering a variety of cancer‐related neurologic problems. LDH‐5 isoenzyme as a percentage of total LDH activity was abnormally elevated (above 10 to 15%) in leptomeningeal infiltration by carcinoma (breast carcinoma, lung carcinoma, and malignant melanoma) but not in other types of CNS metastases. Abnormal LDH isoenzyme patterns were also seen with CSF infections in which a granulocytic pleocytosis was present. In the absence of infection, an elevated LDH isoenzyme 5:1 ratio suggested leptomeningeal tumor and, when used with other CSF markers (beta‐glucuronidase and CEA), LDH isoenzymes aid in early detection of this metastatic neoplastic process. They may also help to differentiate leptomeningeal tumor from other chronic meningitides. Measurement of CSF markers also aids in assessing the effectiveness of treatment since marker levels often vary with the clinical course.</description><subject>Brain Neoplasms - diagnosis</subject><subject>Brain Neoplasms - secondary</subject><subject>Breast Neoplasms</subject><subject>Carcinoembryonic Antigen - cerebrospinal fluid</subject><subject>Female</subject><subject>Glucuronidase - cerebrospinal fluid</subject><subject>Humans</subject><subject>Isoenzymes</subject><subject>L-Lactate Dehydrogenase - cerebrospinal fluid</subject><subject>Lung Neoplasms</subject><subject>Male</subject><subject>Melanoma</subject><subject>Meningeal Neoplasms - diagnosis</subject><subject>Meningeal Neoplasms - secondary</subject><issn>0008-543X</issn><issn>1097-0142</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1981</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkN9r1EAQxxdR6ln9E4R9En3IOfsju8lZhJL6o3B4IH2QKgybZNJbySVnNkdJ__rucWdBHwSfhpnvzHdmPoxdCJgLAPlWQG4TEFq-FnkmwIB4o-1CiDNpUr1YnF9eJMWX4qvMJGgrhJTv1RzmxeqdTK4fsdnD-GM2A4AsSbX69pQ9C-FnTK1M1Qk7sdJAltoZ-7501egrXtN6qof-hjoXiPvQU3c3bShw3_FxTbyigcqhD1vfuZY37c7XvG_41o2eujHwWz-ueZjCSJvoVrkuDjxnTxrXBnpxjKfs6uOHq-Jzslx9uizOl0mlrZRJpk2j83ibalxdljnYhmplqTHQZKWRuSqhNiJWK2Nt1Ctbu9xkmbMgjVCn7NXBdjv0v3YURtz4UFHbuo76XUCrUtCpSmPjj0NjFR8JAzW4HfzGDRMKwD163LPDPTv8jR61RSFwjx4xosc_0aNCwGKFEq-j_cvjHbtyQ_WD-ZF11G8O-q1vafrP3f9c_Zei7gETA6KF</recordid><startdate>19810601</startdate><enddate>19810601</enddate><creator>Fleisher, Martin</creator><creator>Wasserstrom, William R.</creator><creator>Schold, S. Clifford</creator><creator>Schwartz, Morton K.</creator><creator>Posner, Jerome B.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19810601</creationdate><title>Lactic dehydrogenase isoenzymes in the cerebrospinal fluid of patients with systemic cancer</title><author>Fleisher, Martin ; Wasserstrom, William R. ; Schold, S. Clifford ; Schwartz, Morton K. ; Posner, Jerome B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4722-846f490003fadbb907fed37ef60f8b6293b0d617fec677b90c7da9688a702613</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1981</creationdate><topic>Brain Neoplasms - diagnosis</topic><topic>Brain Neoplasms - secondary</topic><topic>Breast Neoplasms</topic><topic>Carcinoembryonic Antigen - cerebrospinal fluid</topic><topic>Female</topic><topic>Glucuronidase - cerebrospinal fluid</topic><topic>Humans</topic><topic>Isoenzymes</topic><topic>L-Lactate Dehydrogenase - cerebrospinal fluid</topic><topic>Lung Neoplasms</topic><topic>Male</topic><topic>Melanoma</topic><topic>Meningeal Neoplasms - diagnosis</topic><topic>Meningeal Neoplasms - secondary</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fleisher, Martin</creatorcontrib><creatorcontrib>Wasserstrom, William R.</creatorcontrib><creatorcontrib>Schold, S. Clifford</creatorcontrib><creatorcontrib>Schwartz, Morton K.</creatorcontrib><creatorcontrib>Posner, Jerome B.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fleisher, Martin</au><au>Wasserstrom, William R.</au><au>Schold, S. Clifford</au><au>Schwartz, Morton K.</au><au>Posner, Jerome B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Lactic dehydrogenase isoenzymes in the cerebrospinal fluid of patients with systemic cancer</atitle><jtitle>Cancer</jtitle><addtitle>Cancer</addtitle><date>1981-06-01</date><risdate>1981</risdate><volume>47</volume><issue>11</issue><spage>2654</spage><epage>2659</epage><pages>2654-2659</pages><issn>0008-543X</issn><eissn>1097-0142</eissn><abstract>Lactic dehydrogenase (LDH) isoenzymes were measured in the cerebrospinal fluid (CSF) in a group of patients suffering a variety of cancer‐related neurologic problems. LDH‐5 isoenzyme as a percentage of total LDH activity was abnormally elevated (above 10 to 15%) in leptomeningeal infiltration by carcinoma (breast carcinoma, lung carcinoma, and malignant melanoma) but not in other types of CNS metastases. Abnormal LDH isoenzyme patterns were also seen with CSF infections in which a granulocytic pleocytosis was present. In the absence of infection, an elevated LDH isoenzyme 5:1 ratio suggested leptomeningeal tumor and, when used with other CSF markers (beta‐glucuronidase and CEA), LDH isoenzymes aid in early detection of this metastatic neoplastic process. They may also help to differentiate leptomeningeal tumor from other chronic meningitides. Measurement of CSF markers also aids in assessing the effectiveness of treatment since marker levels often vary with the clinical course.</abstract><cop>New York</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>7260857</pmid><doi>10.1002/1097-0142(19810601)47:11&lt;2654::AID-CNCR2820471122&gt;3.0.CO;2-Z</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0008-543X
ispartof Cancer, 1981-06, Vol.47 (11), p.2654-2659
issn 0008-543X
1097-0142
language eng
recordid cdi_proquest_miscellaneous_73504535
source MEDLINE; Alma/SFX Local Collection
subjects Brain Neoplasms - diagnosis
Brain Neoplasms - secondary
Breast Neoplasms
Carcinoembryonic Antigen - cerebrospinal fluid
Female
Glucuronidase - cerebrospinal fluid
Humans
Isoenzymes
L-Lactate Dehydrogenase - cerebrospinal fluid
Lung Neoplasms
Male
Melanoma
Meningeal Neoplasms - diagnosis
Meningeal Neoplasms - secondary
title Lactic dehydrogenase isoenzymes in the cerebrospinal fluid of patients with systemic cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T05%3A29%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Lactic%20dehydrogenase%20isoenzymes%20in%20the%20cerebrospinal%20fluid%20of%20patients%20with%20systemic%20cancer&rft.jtitle=Cancer&rft.au=Fleisher,%20Martin&rft.date=1981-06-01&rft.volume=47&rft.issue=11&rft.spage=2654&rft.epage=2659&rft.pages=2654-2659&rft.issn=0008-543X&rft.eissn=1097-0142&rft_id=info:doi/10.1002/1097-0142(19810601)47:11%3C2654::AID-CNCR2820471122%3E3.0.CO;2-Z&rft_dat=%3Cproquest_cross%3E73504535%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73504535&rft_id=info:pmid/7260857&rfr_iscdi=true